-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Oncternal Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2014 to Q3 2024.
- Oncternal Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 2.96M shares, a 0.41% increase year-over-year.
- Oncternal Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2.94M shares, a 11.8% increase from 2022.
- Oncternal Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 2.63M shares, a 94.7% decline from 2021.
- Oncternal Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 49.3M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)